These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 33572742)
1. Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling. Bhatt AB; Patel S; Matossian MD; Ucar DA; Miele L; Burow ME; Flaherty PT; Cavanaugh JE Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572742 [TBL] [Abstract][Full Text] [Related]
2. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis. Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274 [TBL] [Abstract][Full Text] [Related]
4. Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner. Jiang W; Cai F; Xu H; Lu Y; Chen J; Liu J; Cao N; Zhang X; Chen X; Huang Q; Zhuang H; Hua ZC Protein Cell; 2020 Nov; 11(11):825-845. PubMed ID: 32144580 [TBL] [Abstract][Full Text] [Related]
5. miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5. Zhai L; Ma C; Li W; Yang S; Liu Z Mol Carcinog; 2016 Dec; 55(12):1990-2000. PubMed ID: 26618772 [TBL] [Abstract][Full Text] [Related]
6. Sulforaphane inhibits epithelial-mesenchymal transition by activating extracellular signal-regulated kinase 5 in lung cancer cells. Chen Y; Chen JQ; Ge MM; Zhang Q; Wang XQ; Zhu JY; Xie CF; Li XT; Zhong CY; Han HY J Nutr Biochem; 2019 Oct; 72():108219. PubMed ID: 31473507 [TBL] [Abstract][Full Text] [Related]
7. Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway. Sun X; Zhang T; Deng Q; Zhou Q; Sun X; Li E; Yu D; Zhong C Mol Cells; 2018 Mar; 41(3):188-197. PubMed ID: 29463068 [TBL] [Abstract][Full Text] [Related]
8. MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis. Antoon JW; Martin EC; Lai R; Salvo VA; Tang Y; Nitzchke AM; Elliott S; Nam SY; Xiong W; Rhodes LV; Collins-Burow B; David O; Wang G; Shan B; Beckman BS; Nephew KP; Burow ME PLoS One; 2013; 8(8):e69291. PubMed ID: 23950888 [TBL] [Abstract][Full Text] [Related]
10. Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells. Liu Z; Liu J; Zhao L; Geng H; Ma J; Zhang Z; Yu D; Zhong C Int J Oncol; 2017 Apr; 50(4):1321-1329. PubMed ID: 28259934 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis. Liu F; Zhang H; Song H Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304 [TBL] [Abstract][Full Text] [Related]
12. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor. Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359 [TBL] [Abstract][Full Text] [Related]
13. The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion. Xu Q; Zhang J; Telfer BA; Zhang H; Ali N; Chen F; Risa B; Pearson AJ; Zhang W; Finegan KG; Ucar A; Giurisato E; Tournier C Oncogene; 2021 Jun; 40(23):3929-3941. PubMed ID: 33981002 [TBL] [Abstract][Full Text] [Related]
14. Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer. Chattopadhyay I; Ambati R; Gundamaraju R Mediators Inflamm; 2021; 2021():9918379. PubMed ID: 34220337 [TBL] [Abstract][Full Text] [Related]
16. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition]. Yuki R Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542 [TBL] [Abstract][Full Text] [Related]
17. MEK5/ERK5 pathway: the first fifteen years. Drew BA; Burow ME; Beckman BS Biochim Biophys Acta; 2012 Jan; 1825(1):37-48. PubMed ID: 22020294 [TBL] [Abstract][Full Text] [Related]
18. TGF-beta activates ERK5 in human renal epithelial cells. Browne JA; Pearson AL; Zahr RA; Niculescu-Duvaz I; Baines DL; Dockrell ME Biochem Biophys Res Commun; 2008 Aug; 373(3):440-4. PubMed ID: 18588859 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5. Wu J; Cui H; Zhu Z; Wang L Biochem Biophys Res Commun; 2016 Sep; 478(3):1158-64. PubMed ID: 27545608 [TBL] [Abstract][Full Text] [Related]
20. Impact of ERK5 on the Hallmarks of Cancer. Stecca B; Rovida E Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]